Old Web
English
Sign In
Acemap
>
authorDetail
>
Mojtaba Keshavarz
Mojtaba Keshavarz
Bushehr University of Medical Sciences
Medicine
Antagonist
Drug
Athletes
Performance-enhancing drugs
5
Papers
35
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Amelioration of Pentylenetetrazole-Induced Seizures by Modulators of Sigma, N-Methyl-D-Aspartate, and Ryanodine Receptors in Mice
2017
Iranian Journal of Medical Sciences
Mojtaba Keshavarz
Behdad Yekzaman
Show All
Source
Cite
Save
Citations (3)
Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders
2017
Iranian Journal of Psychiatry
Afshin Ostovar
Mohammad Javad Haerinejad
Samad Akbarzadeh
Mojtaba Keshavarz
Show All
Source
Cite
Save
Citations (0)
Involvement of PPARγ in the protective action of tropisetron in an experimental model of ulcerative colitis
2016
Immunopharmacology and Immunotoxicology
Reza Rahimian
Mohammad Reza Zirak
Mojtaba Keshavarz
Nahid Fakhraei
Ahmad Mohammadi Farani
Hanan Hamdi
Kazem Mousavizadeh
Show All
Source
Cite
Save
Citations (17)
Dantrolene: A Selective Ryanodine Receptor Antagonist, Protects Against Pentylenetetrazole-Induced Seizure in Mice.
2016
Acta medica Iranica
Mojtaba Keshavarz
Morteza Fotouhi
Alireza Rasti
Show All
Source
Cite
Save
Citations (4)
The Prevalence and Characteristics of Performance-Enhancing Drug Use Among Bodybuilding Athletes in the South of Iran, Bushehr
2016
Asian journal of sports medicine
Mohammad Javad Haerinejad
Afshin Ostovar
Mohamad Reza Farzaneh
Mojtaba Keshavarz
Show All
Source
Cite
Save
Citations (11)
1